Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Whellan

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
American Heart Journal|September 29, 2014
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studiesDavid J Whellan, Jay L Goldstein, Byron L Cryer, et al.
Annals of Internal Medicine|September 17, 2009
Method for establishing authorship in a multicenter clinical trialDavid J Whellan, Stephen J Ellis, William E Kraus, et al.
American Heart Journal|March 29, 2008
Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of careMonica R Shah, David J Whellan, Eric D Peterson, et al.
Journal of the American College of Cardiology|December 3, 2014
Clinical implications of chronic heart failure phenotypes defined by cluster analysisTariq Ahmad, Michael J Pencina, Phillip J Schulte, et al.
American Heart Journal|May 31, 2022
Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trialJacob B Pierce, Robert J Mentz, Jie-Lena Sun, et al.
JACC. Heart Failure|March 13, 2017
A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot StudyGordon R Reeves, David J Whellan, Christopher M O'Connor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 6, 2015
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failureTodd Dardas, Yanhong Li, Shelby D Reed, et al.
JACC. Heart Failure|September 27, 2022
Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF: Insights From REHAB-HFAnthony E Peters, Dalane W Kitzman, Haiying Chen, et al.
European Journal of Heart Failure|September 1, 2018
Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTIONNancy Luo, Christopher M O'Connor, Lauren B Cooper, et al.
Journal of the American College of Cardiology|March 25, 2017
Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF TrialChristopher M O'Connor, David J Whellan, Mona Fiuzat, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
American Heart Journal|September 29, 2014
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studiesDavid J Whellan, Jay L Goldstein, Byron L Cryer, et al.
Annals of Internal Medicine|September 17, 2009
Method for establishing authorship in a multicenter clinical trialDavid J Whellan, Stephen J Ellis, William E Kraus, et al.
American Heart Journal|March 29, 2008
Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of careMonica R Shah, David J Whellan, Eric D Peterson, et al.
Journal of the American College of Cardiology|December 3, 2014
Clinical implications of chronic heart failure phenotypes defined by cluster analysisTariq Ahmad, Michael J Pencina, Phillip J Schulte, et al.
American Heart Journal|May 31, 2022
Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trialJacob B Pierce, Robert J Mentz, Jie-Lena Sun, et al.
JACC. Heart Failure|March 13, 2017
A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot StudyGordon R Reeves, David J Whellan, Christopher M O'Connor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 6, 2015
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failureTodd Dardas, Yanhong Li, Shelby D Reed, et al.
JACC. Heart Failure|September 27, 2022
Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF: Insights From REHAB-HFAnthony E Peters, Dalane W Kitzman, Haiying Chen, et al.
European Journal of Heart Failure|September 1, 2018
Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTIONNancy Luo, Christopher M O'Connor, Lauren B Cooper, et al.
Journal of the American College of Cardiology|March 25, 2017
Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF TrialChristopher M O'Connor, David J Whellan, Mona Fiuzat, et al.
Pageof 19